NCT00116818View on ClinicalTrials.gov

A Study of GW685698X for the Treatment Of Perennial Allergic Rhinitis in Adolescents and Adults

PHASE3CompletedINTERVENTIONAL

Enrollment

90

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

May 31, 2005

Study Completion Date

May 31, 2005

Conditions

Rhinitis, Allergic, Perennial

Interventions

DRUG

GW685698X aqueous nasal spray

Trial Locations (2)

78229

GSK Investigational Site, San Antonio

L4W 1N2

GSK Investigational Site, Mississauga

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY